Received Mar 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | 2088619 | — |
No other AE; The office administered the first ROTATEQ dose to a patient that is 6 months of age. This patient has not received any previous doses; This spontaneous report was received from a nurse and refers to a 6-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 27-Feb-2025, the 6-month-old patient was vaccinated with the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (lot #2088619, expiration date: 09-Mar-2026) (dose, vaccination site and route of administration was not reported) for prophylaxis (product administered to patient of inappropriate age). This patient has not received any previous doses. No symptoms were reported, and no additional details were provided. No other adverse event (AE) pr product quality complaint (PQC) was reported (no adverse event).